Skip to the stories
Wednesday, 4 November 2026
Saved

Next edition

13:24

Headlines

Top Stories

OpenAI acquires Orchestra Bio to expand life sciences suite Rosalind

OpenAI has acquired San Francisco startup Orchestra Bio to integrate its autonomous artificial intelligence agents into the company's Rosalind life sciences platform.

FTMQ Crypto, written by our newsroom0 views

Share
Picture: Decrypt

OpenAI announced on Tuesday that it has acquired Orchestra Bio, a San Francisco startup that develops artificial intelligence agents to assist pharmaceutical companies with program management. The acquisition was reported by Decrypt, SiliconANGLE, Dealroom, PharmTech, BigGo Finance, and Yahoo Finance. The financial terms of the transaction were not disclosed. [1][2][3][4][5][6]

The team and software platform from Orchestra Bio will be integrated into Rosalind, which serves as OpenAI's suite of artificial intelligence models and tools tailored for biologists and chemists. Decrypt and Yahoo Finance reported that Orchestra Bio builds agents designed to help drug developers maintain schedules across sprawling research programs. [1][6]

OpenAI stated that its objective is to assist scientists with making discoveries and managing the necessary operations to bring treatments to patients faster. According to Decrypt and Yahoo Finance, bringing a new medicine from initial conception to approval in the United States currently takes up to 15 years. [1][6]

In computer science, an intelligent agent is defined as an entity that perceives its environment and autonomously takes actions to achieve specific goals. [9]

Share

In short

  • OpenAI announced the acquisition of San Francisco startup Orchestra Bio on Tuesday.
  • Financial terms of the Orchestra Bio acquisition were not disclosed.
  • Orchestra Bio's platform will be folded into Rosalind, OpenAI's suite of tools for life sciences.
  • Bringing a new medicine to approval in the United States can take up to 15 years.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

  1. [1]OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt WorkDecrypt, 14d ago (the report this story comes from)
  2. [2]OpenAI acquires Orchestra Bio to bring AI agents into drug developmentSiliconANGLE, 14d ago
  3. [3]OpenAI buys Orchestra Bio to push AI agents into drug developmentDealroom, 14d ago
  4. [4]OpenAI Bets on Accelerating Drug Development Timelines With Orchestra BioPharmTech.com, 14d ago
  5. [5]OpenAI Buys Orchestra Bio, Pushing AI Agents Into Drug DevelopmentBigGo Finance, 14d ago
  6. [6]OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt WorkYahoo Finance, 14d ago

Background

  1. [7]Star Wars: Knights of the Old Republic (video game) on Wikipedia
  2. [8]The Wire on Wikipedia
  3. [9]Intelligent agent on Wikipedia

Our newsroom writes these reports with the help of software, from the 9 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Related from FTMQ Crypto

Earlier reports of ours on the same people and subjects.

More in Top Stories

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Loading

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.